Compounds > phenylalanine

phenylalanine and 2,4-thiazolidinedione

phenylalanine has been researched along with 2,4-thiazolidinedione in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koivisto, V1
Foley, JE; Gatlin, MR; Rosenstock, J; Shen, SG1
Ishida, H; Kadowaki, T; Kawamori, R1

Reviews

1 review(s) available for phenylalanine and 2,4-thiazolidinedione

ArticleYear
[Insulin analogs and new oral antidiabetic drugs].
    Duodecim; laaketieteellinen aikakauskirja, 1999, Volume: 115, Issue:20

    Topics: Administration, Oral; Carbamates; Cyclohexanes; Diabetes Mellitus; Dose-Response Relationship, Drug; Glucose; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Nateglinide; Phenylalanine; Piperidines; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors

1999

Trials

1 trial(s) available for phenylalanine and 2,4-thiazolidinedione

ArticleYear
Combination therapy with nateglinide and a thiazolidinedione improves glycemic control in type 2 diabetes.
    Diabetes care, 2002, Volume: 25, Issue:9

    Topics: Adult; Aged; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Male; Middle Aged; Nateglinide; Phenylalanine; Thiazoles; Thiazolidinediones; Treatment Outcome

2002

Other Studies

2 other study(ies) available for phenylalanine and 2,4-thiazolidinedione

ArticleYear
[Type 2 diabetes. Regulating insulin according to need].
    MMW Fortschritte der Medizin, 2001, Oct-18, Volume: 143, Issue:42

    Topics: Blood Glucose; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Insulin; Metformin; Nateglinide; Phenylalanine; Thiazoles; Thiazolidinediones

2001
[Achieving better control of blood sugar--understanding of oral hypoglycemic agents according to their characteristics in pharmacological action mechanism (discussion)].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62, Issue:4

    Topics: Administration, Oral; Cardiovascular Diseases; Cyclohexanes; Diabetes Complications; Diabetes Mellitus; Drug Therapy, Combination; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Hypoglycemic Agents; Indoles; Inositol; Insulin; Insulin Resistance; Insulin Secretion; Isoindoles; Nateglinide; Phenylalanine; Risk Factors; Stimulation, Chemical; Sulfonylurea Compounds; Thiazolidinediones

2004